Brief: Aelis Farma Presented Preclinical Data Showing Efficacy Of AEF0217 In Genetic Mouse Model Of Autism Spectrum Disorder
12/06/2023 06:17
June 12 (Reuters) - Aelis Farma SA AELIS.PA :
* PRECLINICAL DATA DEMONSTRATING EFFICACY OF AEF0217 IN A
GENETIC
MOUSE MODEL OF AUTISM SPECTRUM DISORDER HAS BEEN PRESENTED AT
2ND EUROPEAN CONFERENCE ON PHELAN-MCDERMID SYNDROME
Source text for Eikon: ID:nBw92MJ5Ra
Further company coverage: AELIS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Aelis Farma SA
See all newsBrief: Aelis Farma Availability Of 2025 Half-Year Financial Report
Brief: Euronext: Quarterly Review Of CAC Family
Brief: Aelis Farma Confirms Its 2025 Outlook
Brief: Aelis Farma Announces The Final Analysis Of Phase 2B Clinical Trial In Cannabis Use Disorder With AEF0117
Brief: Aelis Farma Says AEF0217 Well Tolerated With No Safety Concerns Identified